MENU
+Compare
MNKD
Stock ticker: NASDAQ
AS OF
Jul 3, 02:00 PM (EDT)
Price
$3.60
Change
-$0.02 (-0.55%)
Capitalization
1.09B

MNKD MannKind Corp Forecast, Technical & Fundamental Analysis

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension... Show more

Industry: #Biotechnology
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MNKD with price predictions
Jul 02, 2025

Momentum Indicator for MNKD turns negative, indicating new downward trend

MNKD saw its Momentum Indicator move below the 0 level on July 01, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned negative. In of the 87 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for MNKD turned negative on July 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNKD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MNKD entered a downward trend on June 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MNKD's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MNKD advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

MNKD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.522). P/E Ratio (36.000) is within average values for comparable stocks, (58.479). MNKD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (3.422) is also within normal values, averaging (261.553).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MNKD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MNKD is expected to report earnings to fall 26.14% to 5 cents per share on August 06

MannKind Corp MNKD Stock Earnings Reports
Q2'25
Est.
$0.05
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
The last earnings report on May 08 showed earnings per share of 7 cents, beating the estimate of 3 cents. With 1.73M shares outstanding, the current market capitalization sits at 1.09B.
A.I. Advisor
published General Information

General Information

a developer of therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
414
Web
https://www.mannkindcorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRGIX15.95N/A
N/A
Nuveen Core Equity Retire
GACIX46.34N/A
N/A
Gabelli Small Cap Growth I
JRSNX12.21N/A
N/A
JH Adaptive Risk Mgd U.S. Eq N
SLESX11.49N/A
N/A
Invesco Income Advantage U.S. Fund R6
WQAUX12.06N/A
N/A
Westwood Quality AllCap Ultra

MNKD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with VCYT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
+1.12%
VCYT - MNKD
44%
Loosely correlated
+0.92%
LXRX - MNKD
42%
Loosely correlated
+3.03%
INSM - MNKD
40%
Loosely correlated
+0.64%
BLUE - MNKD
38%
Loosely correlated
N/A
UTHR - MNKD
38%
Loosely correlated
+1.48%
More